Spots Global Cancer Trial Database for muscle invasive bladder carcinoma
Every month we try and update this database with for muscle invasive bladder carcinoma cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Futibatinib in Combination With Durvalumab Prior to Cystectomy for the Treatment of Muscle-Invasive Bladder Cancer Patients Who Are Ineligible for Cisplatin-based Therapy | NCT06263153 | Bladder Urothel... Muscle Invasive... Stage II Bladde... Stage IIIA Blad... | Biospecimen Col... Computed Tomogr... Durvalumab Futibatinib Magnetic Resona... Radical Cystect... | 18 Years - | Ohio State University Comprehensive Cancer Center | |
| Chemoradiation for Bladder Preservation After Complete Response to Neoadjuvant Chemotherapy | NCT02145390 | Bladder Cancer Bladder Carcino... Transition Cell... Muscle Invasive... | Transurethral R... Intensity Modul... Expanded Prosta... International P... | 18 Years - | University of Miami | |
| Chemoradiation for Bladder Preservation After Complete Response to Neoadjuvant Chemotherapy | NCT02145390 | Bladder Cancer Bladder Carcino... Transition Cell... Muscle Invasive... | Transurethral R... Intensity Modul... Expanded Prosta... International P... | 18 Years - | University of Miami | |
| A Study of RC48-ADC Combined With JS001 For Perioperative Treatment of Muscle-Invasive Bladder Cancer | NCT05297552 | Muscle Invasive... | RC48-ADC JS001 | 18 Years - | RemeGen Co., Ltd. | |
| Pembrolizumab and Combination Chemotherapy Before Surgery for the Treatment of Muscle-Invasive Bladder Cancer | NCT04383743 | Stage II Bladde... Stage IIIA Blad... Muscle Invasive... | Cisplatin Doxorubicin Methotrexate Pegfilgrastim Pembrolizumab Radical Cystect... Vinblastine Sul... | 18 Years - | University of Washington | |
| Chemoradiotherapy With or Without Atezolizumab in Treating Patients With Localized Muscle Invasive Bladder Cancer | NCT03775265 | Bladder Urothel... Muscle Invasive... Stage II Bladde... Stage IIIA Blad... | Atezolizumab Biopsy of Bladd... Cisplatin Computed Tomogr... Cystoscopy Fluorouracil Gemcitabine Magnetic Resona... Mitomycin Quality-of-Life... Radiation Thera... Survey Administ... Transurethral R... | 18 Years - | National Cancer Institute (NCI) | |
| A Home-Based Prehabilitation Exercise Intervention for Improving Physical Function in Patients Receiving Chemotherapy Before Radical Cystectomy, Get Moving Trial | NCT06040762 | Muscle Invasive... Stage II Bladde... Stage IIIA Blad... | Best Practice Exercise Interv... App-Based Inter... App-Based Inter... Interview Wearable Activi... Physical Perfor... Questionnaire A... | 18 Years - | University of Washington | |
| FL- 101 Study in Non-Metastatic MIBC | NCT05395260 | Muscle Invasive... | FL-101 | 18 Years - | Flame Biosciences | |
| Partial Cystectomy & Extended Pelvic Lymph Node Dissection With SOC Perioperative Systemic Therapy | NCT06290687 | Malignant Neopl... Muscle Invasive... | Neoadjuvant Che... Partial cystect... Adjuvant system... | 19 Years - | Case Comprehensive Cancer Center | |
| Pembrolizumab and Combination Chemotherapy Before Surgery for the Treatment of Muscle-Invasive Bladder Cancer | NCT04383743 | Stage II Bladde... Stage IIIA Blad... Muscle Invasive... | Cisplatin Doxorubicin Methotrexate Pegfilgrastim Pembrolizumab Radical Cystect... Vinblastine Sul... | 18 Years - | University of Washington | |
| Sacituzumab Govitecan Before Radical Cystectomy for the Treatment of Non-Urothelial Muscle Invasive Bladder Cancer | NCT05581589 | Muscle Invasive... Stage II Bladde... Stage IIIA Blad... | Lymphadenectomy Radical Cystect... Sacituzumab Gov... | 18 Years - | University of Washington | |
| A Study of RC48-ADC Combined With AK104 For Perioperative Treatment of Muscle-Invasive Bladder Cancer | NCT06074484 | Muscle Invasive... | RC48-ADC AK104 | 18 Years - | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | |
| Pembrolizumab in Muscle-invasive Bladder Cancer | NCT05406713 | Muscle Invasive... Localized Cance... Urothelial Carc... | Pembrolizumab | 18 Years - | Hoosier Cancer Research Network | |
| Sacituzumab Govitecan Before Radical Cystectomy for the Treatment of Non-Urothelial Muscle Invasive Bladder Cancer | NCT05581589 | Muscle Invasive... Stage II Bladde... Stage IIIA Blad... | Lymphadenectomy Radical Cystect... Sacituzumab Gov... | 18 Years - | University of Washington |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
